News

An aspirin a day really does keep heart attack and stroke away for women, yet fewer than half of American women who could benefit from the simple measure do not take a daily pill, according to recent research.

Home November 06, 2006
Home
News

The FDA has cleared Boston Scientific’s NexStent Carotid Stent and Monorail Delivery System for use in patients with ...

Home November 06, 2006
Home
News

San Francisco-based McKesson announced it has agreed to purchase Per-Se Technologies, Alpharetta, Ga., in a deal worth $1.8 billion. The purchase is expected to close in the first quarter of 2007 if it meets regulatory approval.

Home November 06, 2006
Home
News

The FDA has approved NitroMist (Nitroglycerin Lingual Aerosol) for acute relief of an attack or acute prophylaxis of ...

Home November 05, 2006
Home
News

Washington University surgeons at Barnes-Jewish Hospital, St. Louis, began training at UMC in Tucson on Nov. 2 to become ...

Home November 05, 2006
Home
News

Results from the Phase II MEND-CABG study — which looked at demonstrated the clinical benefits of MC-1 in reducing ...

Home November 05, 2006
Home
News

A new study published in the Oct. 30 edition of “Circulation” calls the onset of peripheral arterial disease (PAD) among ...

Home November 05, 2006
Home
News

Hospitals and other medical facilities across the state of Washington will receive $1 million in grant money allocated ...

Home November 05, 2006
Home
News

A dedicated interventional cardiology track is slated during the 2006 Scientific Sessions of the AHA in Chicago that ...

Home November 05, 2006
Home
News

Well-known cardiologist Eric Topol has been appointed by Scripps Health in San Diego, CA, to lead a new institute to ...

Home November 02, 2006
Home
News

A new cooling pad enters the healthcare market, joining a growing number of cooling systems used to induce hypothermia ...

Home November 02, 2006
Home
News

A new alternative to invasive, painful biopsies for determining heart transplant rejection is both available and ...

Home November 02, 2006
Home
News

November 2006 - Physicians at UT Southwestern Medical Center are part of a multinational clinical trial evaluating the Optimizer System, a unique implantable device designed to treat a larger number of patients with heart failure. UT Southwestern is one of the top enrolling centers of the 50 sites in the U.S.

Home November 02, 2006
Home
News

NewYork-Presbyterian Hospital now offers a new alternative therapy for heart failure patients at risk for sudden cardiac ...

Home November 02, 2006
Home
News

Boston Scientific has launched new software enabling its Left Ventricular (LV) Offset feature in the CONTAK RENEWAL ...

Home November 02, 2006
Home
Subscribe Now